Categories
Latest Industry Intelligence
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
In January 2022, DDW’s Megan Thomas spoke to decision-makers from the drug discovery industry about [...]
A new study has demonstrated the ability of an experimental regenerative medicine to restore bone in an animal. Bone loss is a part of ageing that compromises quality of life and movement in many older people, but regenerative treatments to improve their health and well-being have been limited. The preclinical study, led by Lankenau Institute […]
A new report reveals steadily growing interest in the clinical applications of collagen over the last 10 years. Data analytics company Phesi analysed 2,358 clinical trials involving collagen. In the first 10 months of 2022, there were more than 225 new trials, compared with 125 in 2012. Dr Gen Li, CEO and Founder, Phesi, said: […]
Kizoo Technology Capital has a clear aim – to develop drugs that abate or cure age-related diseases. Lu Rahman spoke to owner, Michael Greve to find out more about this exciting work that aims to make age-related therapies affordable for everyone. Kizoo is investing €300 million in a portfolio of private science-backed biotechnology companies which […]